BSI PD ISO/TS 24560-1:2022
$167.15
Tissue-engineered medical products. MRI evaluation of cartilage – Clinical evaluation of regenerative knee articular cartilage using delayed gadolimium-enhanced MRI of cartilage (dGEMRIC) and T2 mapping
Published By | Publication Date | Number of Pages |
BSI | 2022 | 40 |
PDF Catalog
PDF Pages | PDF Title |
---|---|
2 | National foreword |
6 | Foreword |
7 | Introduction |
9 | 1 Scope 2 Normative references 3 Terms and definitions |
11 | 4 Principles |
12 | 5 T2 mapping evaluation in human knee articular cartilage 5.1 Characterization parameters and methods |
14 | 5.2 T2 value measurement process 5.2.1 Post-processing of imaging 5.2.2 Measurement method |
15 | 5.2.3 ROIs of regenerative cartilage 5.2.4 ROIs of normal control cartilage |
16 | 5.3 T2 value evaluation 5.3.1 Purpose of evaluation 5.3.2 In vivo evaluation of regenerative cartilage with T2 value |
17 | 6 dGEMRIC evaluation in human knee articular cartilage 6.1 Characterization parameters and methods |
18 | 6.2 T1 value measurement process 6.2.1 Post-processing of imaging |
19 | 6.2.2 Measurement method 6.2.3 ROIs of regenerative cartilage 6.2.4 ROIs of normal control cartilage |
20 | 6.3 ΔR1 value calculation 6.4 ΔR1 value evaluation 6.4.1 Purpose of evaluation 6.4.2 In vivo evaluation of regenerative cartilage with ΔR1 values |
22 | 7 Acceptable standard for MR evaluation 7.1 Requirements for MR equipment 7.2 Requirements for MR parameters 7.3 Requirements for the MR longitudinally evaluation 7.4 Exclusion criteria 8 Limitation |
24 | Annex A (informative) Example of measurement results |
34 | Annex B (informative) Introduction of T1ρ MR Imaging technology |
36 | Bibliography |